Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
247 4 |
Ultima descărcare din IBN: 2023-09-13 16:42 |
SM ISO690:2012 MACH, Francois, BAIGENT, Colin N., CATAPANO, Alberico L., NOI, Autori, IVANOV, Victoria. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular riskErratum in:Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.. In: European Heart Journal, 2020, vol. 41, pp. 140-205. ISSN 0195-668X. DOI: https://doi.org/10.1093/eurheartj/ehz455 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
European Heart Journal | ||||||
Volumul 41 / 2020 / ISSN 0195-668X | ||||||
|
||||||
DOI:https://doi.org/10.1093/eurheartj/ehz455 | ||||||
Pag. 140-205 | ||||||
|
||||||
Descarcă PDF | ||||||
Cuvinte-cheie adult, Aged, biomarkers, cardiovascular diseases, consensus, drug therapy, Combination, dyslipidemias, female, Humans, Hypolipidemic Agents, lipids, Male, middle aged, risk assessment, risk factors, Risk Reduction Behavior, treatment outcome |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-175225</cfResPublId> <cfResPublDate>2020-01-01</cfResPublDate> <cfStartPage>140</cfStartPage> <cfISSN>0195-668X</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/175225</cfURI> <cfTitle cfLangCode='EN' cfTrans='o'>2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular riskErratum in:Corrigendum to: 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.</cfTitle> <cfKeyw cfLangCode='EN' cfTrans='o'>adult; Aged; biomarkers; cardiovascular diseases; consensus; drug therapy; Combination; dyslipidemias; female; Humans; Hypolipidemic Agents; lipids; Male; middle aged; risk assessment; risk factors; Risk Reduction Behavior; treatment outcome</cfKeyw> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-81839</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-106121</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-101460</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-93022</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-11735</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfFedId> <cfFedIdId>ibn-doi-175225</cfFedIdId> <cfFedId>10.1093/eurheartj/ehz455</cfFedId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> <cfFedId_Class> <cfClassId>31d222b4-11e0-434b-b5ae-088119c51189</cfClassId> <cfClassSchemeId>bccb3266-689d-4740-a039-c96594b4d916</cfClassSchemeId> </cfFedId_Class> <cfFedId_Srv> <cfSrvId>5123451</cfSrvId> <cfClassId>eda2b2e2-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>5a270628-f593-4ff4-a44a-95660c76e182</cfClassSchemeId> </cfFedId_Srv> </cfFedId> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-81839</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-81839-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> <cfFamilyNames>MacH</cfFamilyNames> <cfFirstNames>Francois</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-106121</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-106121-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> <cfFamilyNames>Baigent</cfFamilyNames> <cfFirstNames>Colin N.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-101460</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-101460-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> <cfFamilyNames>Catapano</cfFamilyNames> <cfFirstNames>Alberico L.</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-93022</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-93022-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> <cfFamilyNames>Noi</cfFamilyNames> <cfFirstNames>Autori</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-11735</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11735-3</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2020-01-01T24:00:00</cfStartDate> <cfFamilyNames>Ivanov</cfFamilyNames> <cfFirstNames>Victoria</cfFirstNames> </cfPersName_Pers> </cfPers> <cfSrv> <cfSrvId>5123451</cfSrvId> <cfName cfLangCode='en' cfTrans='o'>CrossRef DOI prefix service</cfName> <cfDescr cfLangCode='en' cfTrans='o'>The service of issuing DOI prefixes to publishers</cfDescr> <cfKeyw cfLangCode='en' cfTrans='o'>persistent identifier; Digital Object Identifier</cfKeyw> </cfSrv> </CERIF>